TAMSU P.R TEVA

Pays: Israël

Langue: anglais

Source: Ministry of Health

Achète-le

Télécharger Notice patient (PIL)
19-10-2021

Ingrédients actifs:

TAMSULOSIN HYDROCHLORIDE

Disponible depuis:

ABIC MARKETING LTD, ISRAEL

Code ATC:

G04CA02

forme pharmaceutique:

TABLETS PROLONGED RELEASE

Composition:

TAMSULOSIN HYDROCHLORIDE 0.4 MG

Mode d'administration:

PER OS

Type d'ordonnance:

Required

Fabriqué par:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Domaine thérapeutique:

TAMSULOSIN

indications thérapeutiques:

Lower urinary tract symptoms ( LUTS) associated with benign prostatic hyperplasia (BPH).

Date de l'autorisation:

2020-08-30

Notice patient

                                The format of this leaflet was determined by the Ministry of
Health and its content was checked and approved
PATIENT LEAFLET IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed with a doctor's prescription only
TAMSU P.R. TEVA
Prolonged-release tablets
COMPOSITION
Each film-coated, prolonged-release tablet contains:
Tamsulosin hydrochloride 0.4 mg
For information regarding inactive ingredients, see section 6
"Additional information".
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE.
This leaflet contains concise information about the medicine. If you
have additional questions, refer to the doctor or the pharmacist.
This medicine has been prescribed for treatment of your illness.
Do not pass it on to others. It may harm them even if it seems
to you that their illness is similar.
This medicine is not intended for use in children and adolescents
under the age of 18.
1. WHAT IS THE MEDICINE INTENDED FOR?
The medicine is intended for treatment of disturbances of the
lower urinary system associated with a benign prostatic tumor.
THERAPEUTIC CLASS: a selective alpha-1A, alpha-1D adrenoceptor
blocker.
2. BEFORE USING THE MEDICINE:
DO NOT USE THIS MEDICINE IF:
•
You are sensitive (allergic) to tamsulosin or to any of the
other ingredients the medicine contains. Hypersensitivity
can appear as sudden local swelling in the soft tissues of
the body (e.g., throat or tongue), breathing difficulties and/
or itching and rash (angioedema).
•
You have serious liver problems.
•
You have or have had in the past low blood pressure,
dizziness or fainting due to fall in blood pressure, for
example when suddenly changing from a lying position to
sitting or standing (orthostatic hypotension).
SPECIAL WARNINGS REGARDING THE USE OF THE MEDICINE
•
Consult with your doctor before taking this medicine.
•
Like other medicines from the same group, Tamsu P.R. Teva
can cause fainting on rare occasions. When you feel dizzy
or faint, you should sit or lie down until the signs disap
                                
                                Lire le document complet
                                
                            

Documents dans d'autres langues

Notice patient Notice patient arabe 19-10-2021
Notice patient Notice patient hébreu 19-10-2021

Rechercher des alertes liées à ce produit

Afficher l'historique des documents